Selective inhibition of the kinase DYRK1A by targeting its folding process
Kinase inhibitors are important drugs and usually target the ATP binding pocket of kinases. Here, Kii et al.report a completely new type of kinase inhibitor that specifically targets the protein folding intermediate state, but not the mature form, of the protein kinase DYRK1A.
Guardado en:
Autores principales: | Isao Kii, Yuto Sumida, Toshiyasu Goto, Rie Sonamoto, Yukiko Okuno, Suguru Yoshida, Tomoe Kato-Sumida, Yuka Koike, Minako Abe, Yosuke Nonaka, Teikichi Ikura, Nobutoshi Ito, Hiroshi Shibuya, Takamitsu Hosoya, Masatoshi Hagiwara |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc58fcf33b4145468837fef116260032 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain
por: Samira Abu Jhaisha, et al.
Publicado: (2017) -
Chiral deaza-coelenterazine analogs for probing a substrate-binding site in the Ca2+-binding photoprotein aequorin.
por: Satoshi Inouye, et al.
Publicado: (2021) -
Remodeling of actin cytoskeleton in mouse periosteal cells under mechanical loading induces periosteal cell proliferation during bone formation.
por: Daisuke Sakai, et al.
Publicado: (2011) -
Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A.
por: Fayçal Guedj, et al.
Publicado: (2009) -
DYRK1A Overexpression in Mice Downregulates the Gonadotropic Axis and Disturbs Early Stages of Spermatogenesis
por: Rodolphe Dard, et al.
Publicado: (2021)